HomeInsightsPE

Kimia Biosciences Ltd P/E Ratio

Kimia Biosciences Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.0 K

stocks traded

Last Updated time: 22 Jul 9.00 AM

Image

Kimia Biosciences Ltd

NSE: KIMIABIOSCIEN

PE

0

Last updated : 22 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Kimia Biosciences Ltd is 0 as of 22 Jul 9.00 AM .a1#The P/E Ratio of Kimia Biosciences Ltd changed from 13.5 on March 2019 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years. a1#The Latest Trading Price of Kimia Biosciences Ltd is ₹ 50.25 as of 22 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.6 in 5 years. This represents a CAGR of -0.64%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 23.8. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 38.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.4. In 2024a1#The Market Cap of Kimia Biosciences Ltd changed from ₹ 51.88 crore on March 2019 to ₹ 153.77 crore on March 2023 . This represents a CAGR of 24.27% over 5 years. a1#The Revenue of Kimia Biosciences Ltd changed from ₹ 37.04 crore to ₹ 30.6 crore over 8 quarters. This represents a CAGR of -9.11% a1#The EBITDA of Kimia Biosciences Ltd changed from ₹ 3.12 crore to ₹ 4.47 crore over 8 quarters. This represents a CAGR of 19.70% a1#The Net Pr of Kimia Biosciences Ltd changed from ₹ 1.1 crore to ₹ 1.8 crore over 8 quarters. This represents a CAGR of 27.92% a1#The Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Kimia Biosciences Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Kimia Biosciences Ltd

Period
Mar '1913.5
Mar '2066.7
Mar '2135.1
Mar '220
Mar '230

Company Fundamentals for Kimia Biosciences Ltd

Market Cap

237 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

717.7

Day’s High

52.65

Day’s Low

46.73

DTE *

132.0

ROE *

-1603.8

52 Week High

58.4

52 Week Low

31.99

ROCE *

-4.2

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

Image

Kimia Biosciences Ltd

NSE: KIMIABIOSCIEN

PRICE

50.25

-0.61 (-1.20%)

stock direction

Last updated : 22 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

Asset Value vs Market Value of Kimia Biosciences Ltd

Market Value

238

Asset Value

89

1.7 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Kimia Biosciences Ltd0237
Sun Pharmaceuticals Industries Ltd38380,990
Divis Laboratories Ltd75120,383
Cipla Ltd28120,296
Zydus Lifesciences Ltd30116,160
Dr Reddys Laboratories Ltd20112,931

Key Valuation Metric of Kimia Biosciences Ltd

Earnings

-5 Cr

0.0 X

PE Ratio

Market Cap

₹237.75Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-5 Cr

0.0 X

PE Ratio

Market Cap

₹237.75Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Kimia Biosciences Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Kimia Biosciences Ltd

Period
Mar '1952
Mar '2093
Mar '21180
Mar '22178
Mar '23154

* All values are a in crore

×

Historical Revenue of Kimia Biosciences Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Kimia Biosciences Ltd

Period
Jun '2237
Sep '2241
Dec '2229
Mar '2323
Jun '2324
Sep '2325
Dec '2327
Mar '2431

* All values are a in crore

×

Historical EBITDA of Kimia Biosciences Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Kimia Biosciences Ltd

Period
Jun '223
Sep '221
Dec '22-3
Mar '23-6
Jun '23-2
Sep '23-1
Dec '230
Mar '244

* All values are a in crore

×

Historical Net Profit of Kimia Biosciences Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Kimia Biosciences Ltd

Period
Jun '221
Sep '22-1
Dec '22-3
Mar '23-6
Jun '23-3
Sep '23-2
Dec '23-2
Mar '242

* All values are a in crore

×

Historical Dividend Payout of Kimia Biosciences Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Kimia Biosciences Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Kimia Biosciences Ltd

About Kimia Biosciences Ltd

    Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Hon'ble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Ho'ble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Hon'ble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview. During the year 2017-18, the Scheme of Arrangement for Amalgamation of the Company with M/s Kimia Biosciences Limited was made effective from September 17, 2018. Upon Scheme of Amalgamation becoming effective on 17.09.2018, M/s. Kimia Biosciences Limited Holding Company having 37,28,100 Equity Shares (50.48%) of Rs. 10/- each of the Company got merged under reverse merger with the Company.

Kimia Biosciences Ltd News Hub

News

Kimia Biosciences to conduct board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 28 June ...

Read more

24 Jun 202410:15

News

Kimia Biosciences to convene board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

24 May 202416:41

News

Kimia Biosciences schedules board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

09 Feb 202414:52

News

Kimia Biosciences to conduct board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 9 Novemb...

Read more

03 Nov 202315:57

News

Kimia Biosciences schedules AGM

Kimia Biosciences announced that the 30th Annual General Meeting (AGM) of the company will...

Read more

05 Sep 202315:34

News

Kimia Biosciences schedules board meeting

Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 14 Augus...

Read more

10 Aug 202312:28

Product Composition by Percentage (Revenue)

FAQs for PE of Kimia Biosciences Ltd

What is Kimia Biosciences Ltd current share price?

The current market price of Kimia Biosciences Ltd as of July 22, 2024 is ₹50.25.

What is Kimia Biosciences Ltd's market cap?

Kimia Biosciences Ltd's market capitalisation stood at ₹237 Cr as of July 22, 2024

What are Kimia Biosciences Ltd's total net assets?

According to Kimia Biosciences Ltd's most recent financial filings, the company's net assets total ₹88.5 Cr.

Is Kimia Biosciences Ltd making a profit or loss?

Kimia Biosciences Ltd's net Profit as of July 22, 2024 is close to ₹-5 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199